RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
China Resources Medical Holdings Company - Stock

China Resources Medical Holdings Company Revenue 2024

China Resources Medical Holdings Company Revenue

10.91 B CNY

Ticker

1515.HK

ISIN

KYG2133W1087

WKN

A2DHMW

In 2024, China Resources Medical Holdings Company's sales reached 10.91 B CNY, a 7.96% difference from the 10.11 B CNY sales recorded in the previous year.

The China Resources Medical Holdings Company Revenue history

YEARREVENUE (undefined CNY)GROSS MARGIN (%)
2026e12.1515,68
2025e11.4616,63
2024e10.9117,47
202310.1118,86
20227.916,53
20214.4520,99
20202.7523,14
20192.1236,04
20182.0636,74
20171.8835,59
20161.5326,53
20151.3724,02
20141.2124,68
20130.8923,97
20120.7624,38
20110.5124,08
20100.3923,57

China Resources Medical Holdings Company Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into China Resources Medical Holdings Company, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by China Resources Medical Holdings Company from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects China Resources Medical Holdings Company’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of China Resources Medical Holdings Company. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into China Resources Medical Holdings Company’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing China Resources Medical Holdings Company’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on China Resources Medical Holdings Company’s growth potential.

China Resources Medical Holdings Company Revenue, Profit, and EBIT History

DateChina Resources Medical Holdings Company RevenueChina Resources Medical Holdings Company EBITChina Resources Medical Holdings Company Net Income
2026e12.15 B undefined1.33 B undefined906.71 M undefined
2025e11.46 B undefined1.28 B undefined801.58 M undefined
2024e10.91 B undefined1.14 B undefined687.69 M undefined
202310.11 B undefined1.02 B undefined257.68 M undefined
20227.9 B undefined593.7 M undefined265.86 M undefined
20214.45 B undefined354.33 M undefined417.92 M undefined
20202.75 B undefined300.37 M undefined310.13 M undefined
20192.12 B undefined516.91 M undefined390.87 M undefined
20182.06 B undefined537.35 M undefined430.9 M undefined
20171.88 B undefined460.93 M undefined421.03 M undefined
20161.53 B undefined289.12 M undefined-1.51 B undefined
20151.37 B undefined230.19 M undefined167.05 M undefined
20141.21 B undefined256.29 M undefined230.05 M undefined
2013887.4 M undefined199.1 M undefined90 M undefined
2012758 M undefined164.6 M undefined101.1 M undefined
2011509.5 M undefined90.9 M undefined48.1 M undefined
2010394.1 M undefined67.5 M undefined42.8 M undefined

China Resources Medical Holdings Company stock margins

The China Resources Medical Holdings Company margin analysis displays the gross margin, EBIT margin, as well as the profit margin of China Resources Medical Holdings Company. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for China Resources Medical Holdings Company.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the China Resources Medical Holdings Company's sales revenue. A higher gross margin percentage indicates that the China Resources Medical Holdings Company retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the China Resources Medical Holdings Company's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the China Resources Medical Holdings Company's total revenue generated. When comparing the revenue margin year over year, investors can gauge the China Resources Medical Holdings Company's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the China Resources Medical Holdings Company. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the China Resources Medical Holdings Company's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

China Resources Medical Holdings Company Margin History

China Resources Medical Holdings Company Gross marginChina Resources Medical Holdings Company Profit marginChina Resources Medical Holdings Company EBIT marginChina Resources Medical Holdings Company Profit margin
2026e18.86 %10.91 %7.46 %
2025e18.86 %11.16 %7 %
2024e18.86 %10.41 %6.3 %
202318.86 %10.12 %2.55 %
202216.53 %7.51 %3.36 %
202120.99 %7.97 %9.4 %
202023.14 %10.92 %11.27 %
201936.04 %24.44 %18.48 %
201836.74 %26.09 %20.92 %
201735.59 %24.55 %22.42 %
201626.53 %18.86 %-98.31 %
201524.02 %16.77 %12.17 %
201424.68 %21.25 %19.07 %
201323.97 %22.44 %10.14 %
201224.38 %21.72 %13.34 %
201124.08 %17.84 %9.44 %
201023.57 %17.13 %10.86 %

China Resources Medical Holdings Company Aktienanalyse

What does China Resources Medical Holdings Company do?

China Resources Medical Holdings Company Limited (CR Medical) is a leading healthcare service provider in China. It was established in 2001 and is headquartered in Hong Kong. The company belongs to China Resources Group, one of the largest companies in China. History: CR Medical has a long history and experience in the healthcare sector. It was founded in Hong Kong in 2001 and in the same year, it also acquired Chengdu Xinhua Hospital, one of the largest hospitals in China. In 2015, the company opened its first medical center in Hong Kong. In 2016, it opened the first China Wellness Center (CWC) in Beijing and the first medical center in Shanghai to promote the growth of its healthcare services in China. In 2018, the company expanded its healthcare services through the acquisition of Bayley & Jackson Medical Centre, a renowned private hospital in Hong Kong. Business model: CR Medical is an integrated healthcare company. It offers a wide range of services, including hospitals, medical centers, pharmacies, healthcare products, and diagnostic and pathology services. The company consists of three main divisions: China Resources Peking Hospital, China Resources Xian Military Hospital, and China Resources Bayley & Jackson Medical Centre. Each of these divisions offers a wide range of healthcare services. Products and services: CR Medical provides a wide range of healthcare services, including hospitals, medical centers, pharmacies, healthcare products, and diagnostic and pathology services. Hospitals: CR Medical operates several hospitals in China, including China Resources Peking Hospital, China Resources Xian Military Hospital, and Bayley & Jackson Medical Centre in Hong Kong. Medical centers: The company also operates multiple medical centers in China and Hong Kong, including China Wellness Center and CR Xian Hanguang Health Management Center. Pharmacies: CR Medical is also a leading provider of pharmacies in China. It operates over 370 pharmacies in China under the name Mims. Healthcare products: CR Medical also produces its own healthcare products, including traditional Chinese medicine, dietary supplements, and cosmetics. Diagnostic and pathology services: CR Medical also offers diagnostic and pathology services to monitor and improve customers' health. Conclusion: CR Medical is a leading healthcare service provider in China. The company operates hospitals, medical centers, pharmacies, and produces healthcare products. CR Medical is an integrated healthcare company providing a wide range of services to improve the health of its customers. China Resources Medical Holdings Company ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding China Resources Medical Holdings Company's Sales Figures

The sales figures of China Resources Medical Holdings Company originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing China Resources Medical Holdings Company’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize China Resources Medical Holdings Company's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in China Resources Medical Holdings Company’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about China Resources Medical Holdings Company Stock

How much revenue did China Resources Medical Holdings Company generate this year?

China Resources Medical Holdings Company has achieved a revenue of 10.91 B CNY this year.

How much was the turnover of the company China Resources Medical Holdings Company compared to the previous year?

The revenue of China Resources Medical Holdings Company has increased by 7.96% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of China Resources Medical Holdings Company?

The revenue of China Resources Medical Holdings Company is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of China Resources Medical Holdings Company measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of China Resources Medical Holdings Company so important for investors?

The revenue of China Resources Medical Holdings Company is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does China Resources Medical Holdings Company pay?

Over the past 12 months, China Resources Medical Holdings Company paid a dividend of 0.04 CNY . This corresponds to a dividend yield of about 1.04 %. For the coming 12 months, China Resources Medical Holdings Company is expected to pay a dividend of 0.04 CNY.

What is the dividend yield of China Resources Medical Holdings Company?

The current dividend yield of China Resources Medical Holdings Company is 1.04 %.

When does China Resources Medical Holdings Company pay dividends?

China Resources Medical Holdings Company pays a quarterly dividend. This is distributed in the months of July, July, July, July.

How secure is the dividend of China Resources Medical Holdings Company?

China Resources Medical Holdings Company paid dividends every year for the past 13 years.

What is the dividend of China Resources Medical Holdings Company?

For the upcoming 12 months, dividends amounting to 0.04 CNY are expected. This corresponds to a dividend yield of 1.06 %.

In which sector is China Resources Medical Holdings Company located?

China Resources Medical Holdings Company is assigned to the 'Health' sector.

Wann musste ich die Aktien von China Resources Medical Holdings Company kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China Resources Medical Holdings Company from 7/19/2024 amounting to 0.06 CNY, you needed to have the stock in your portfolio before the ex-date on 6/7/2024.

When did China Resources Medical Holdings Company pay the last dividend?

The last dividend was paid out on 7/19/2024.

What was the dividend of China Resources Medical Holdings Company in the year 2023?

In the year 2023, China Resources Medical Holdings Company distributed 0.12 CNY as dividends.

In which currency does China Resources Medical Holdings Company pay out the dividend?

The dividends of China Resources Medical Holdings Company are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China Resources Medical Holdings Company

Our stock analysis for China Resources Medical Holdings Company Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China Resources Medical Holdings Company Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.